Ironwood Pharmaceuticals (IRWD) Prepaid Assets (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Prepaid Assets of $6.0 million for Q1 2026, down 50.08% sequentially from $12.0 million in Q4 2025, and down 51.51% YoY from $12.3 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Prepaid Assets (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $6.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 51.51% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 51.51% YoY) and the FY2025 annual result came in at $12.0 million, changed 0.45% from the prior year.
- Prepaid Assets retreated to $6.0 million in Q1 2026 per IRWD's latest filing, from $12.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $22.5 million in Q2 2023 and troughed at $6.0 million in Q1 2026.
- A 5-year average of $12.1 million and a median of $12.0 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets jumped 158.34% in 2023, then plunged 51.51% in 2026.
- Over 5 years, Prepaid Assets stood at $7.7 million in 2022, then soared by 55.7% to $12.0 million in 2023, then retreated by 0.74% to $11.9 million in 2024, then rose by 0.45% to $12.0 million in 2025, then plunged by 50.08% to $6.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.0 million, $12.0 million, and $13.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.34 Mn |
| Mar 31, 2026 | 5.98 Mn |
| Dec 31, 2025 | 11.98 Mn |
| Sep 30, 2025 | 13.07 Mn |
| Jun 30, 2025 | 12.73 Mn |
| Mar 31, 2025 | 12.33 Mn |
| Dec 31, 2024 | 11.92 Mn |
| Sep 30, 2024 | 14.19 Mn |
| Jun 30, 2024 | 14.55 Mn |
| Mar 31, 2024 | 14.62 Mn |
| Dec 31, 2023 | 12.01 Mn |
| Sep 30, 2023 | 18.11 Mn |
| Jun 30, 2023 | 22.50 Mn |
| Mar 31, 2023 | 9.03 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 7.01 Mn |
| Jun 30, 2022 | 9.85 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Dec 31, 2021 | 8.69 Mn |
| Sep 30, 2021 | 10.22 Mn |